Managing a Prospective Liver Transplant Recipient on the Waiting List.

[1]  Yong-Hong Wang,et al.  Mesenchymal Stem Cell Therapy in Acute Liver Failure , 2023, Gut and liver.

[2]  Yawei Feng,et al.  Development and validation of a practical machine learning model to predict sepsis after liver transplantation , 2023, Annals of medicine.

[3]  Richard S. Kwon,et al.  American Society for Gastrointestinal Endoscopy guideline on management of post-liver transplant biliary strictures: methodology and review of evidence. , 2023, Gastrointestinal endoscopy.

[4]  O. Giouleme,et al.  Effects of an active lifestyle on the physical frailty of liver transplant candidates , 2022, World journal of transplantation.

[5]  K. Sasaki,et al.  Outcomes of Liver Transplantation in Patients With Preexisting Coronary Artery Disease , 2022, Transplantation.

[6]  A. Berzigotti,et al.  Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII - an update. , 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[7]  Wei Lu,et al.  Esophageal variceal ligation plus sclerotherapy vs. ligation alone for the treatment of esophageal varices , 2022, Frontiers in Surgery.

[8]  L. Pengel,et al.  Does Exercise Training Improve Physical Fitness and Health in Adult Liver Transplant Recipients? A Systematic Review and Meta-analysis , 2022, Transplantation.

[9]  A. Zipprich,et al.  Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients , 2022, Critical Care.

[10]  V. Wu,et al.  Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review , 2022, Hepatology International.

[11]  E. Tapper,et al.  Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  J. Bajaj,et al.  Inadequate practices for hepatic encephalopathy management in the inpatient setting , 2022, Journal of hospital medicine.

[13]  J. Thachil,et al.  Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH , 2022, Journal of thrombosis and haemostasis : JTH.

[14]  A. Chakrabarti,et al.  Cirrhosis and fungal infections‐a cocktail for catastrophe: A systematic review and meta‐analysis with machine learning , 2022, Mycoses.

[15]  F. Lammert,et al.  Final safety and efficacy results from a 106 real‐world patients registry with an ascites‐mobilizing pump , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[16]  N. Reddy,et al.  EARLY DIAGNOSIS AND PREVENTION OF INFECTIONS IN CIRRHOSIS. , 2022, Seminars in liver disease.

[17]  E. Flores-Villalba,et al.  Intraoperative and postoperative impact of pretransplantation transjugular intrahepatic portosystemic shunts in orthotopic liver transplantations: A systematic review and meta-analysis. , 2022, Turkish journal of surgery.

[18]  D. Thabut,et al.  EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. , 2022, Journal of hepatology.

[19]  M. Trauner,et al.  Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event , 2022, JHEP reports : innovation in hepatology.

[20]  M. Premkumar,et al.  The challenges of ascites management: An Indian perspective , 2022, Clinical liver disease.

[21]  J. Pratschke,et al.  Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  M. Borad,et al.  Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation , 2022, Cancers.

[23]  S. Sarin,et al.  A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. , 2022, Journal of hepatology.

[24]  J. Trebicka,et al.  Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure , 2022, Transplant International.

[25]  L. Boulware,et al.  A scoping review of inequities in access to organ transplant in the United States , 2022, International Journal for Equity in Health.

[26]  V. Hernández-Gea,et al.  The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow’s Triad , 2022, Journal of clinical medicine.

[27]  S. Sarin,et al.  Effect of long-term aggressive nutrition therapy on survival in patients with alcohol-related cirrhosis: A randomized controlled trial , 2022, Indian Journal of Gastroenterology.

[28]  G. Piñeiro,et al.  Management of acute renal replacement therapy in critically ill cirrhotic patients , 2022, Clinical kidney journal.

[29]  Y. Kono,et al.  Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  B. Sharma,et al.  L‐ornithine L‐aspartate in acute treatment of severe hepatic encephalopathy: A double‐blind randomized controlled trial , 2021, Hepatology.

[31]  D. Ganger,et al.  Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis , 2021, Hepatology communications.

[32]  M. Machado,et al.  Impact of pretransplant frailty and sarcopenia on the post-transplant prognosis of patients with liver cirrhosis: a systematic review , 2021, European journal of gastroenterology & hepatology.

[33]  Xu‐yong Wei,et al.  Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides , 2021, Journal of hepatocellular carcinoma.

[34]  P. Salvalaggio.  Geographic disparities in transplantation , 2021, Current opinion in organ transplantation.

[35]  W. Qureshi,et al.  N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies , 2021, Przeglad gastroenterologiczny.

[36]  Pramod Kumar,et al.  Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis , 2021, EClinicalMedicine.

[37]  E. Björnsson.  Clinical management of patients with drug‐induced liver injury (DILI) , 2021, United European gastroenterology journal.

[38]  K. Reddy,et al.  The Evolving Challenge of Infections in Cirrhosis. , 2021, The New England journal of medicine.

[39]  M. Rela,et al.  Why Are There So Many Liver Transplants from Living Donors In Asia And So Few In Europe And The US? , 2021, Journal of hepatology.

[40]  F. Saner,et al.  Hyponatremia and Liver Transplantation: A Narrative Review. , 2021, Journal of cardiothoracic and vascular anesthesia.

[41]  W. Kim,et al.  Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021, Hepatology.

[42]  S. Sarin,et al.  Standard-volume plasma-exchange improves outcomes in patients with acute liver failure - A Randomized Controlled Trial. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  M. Bajpai,et al.  Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure , 2020, Journal of clinical apheresis.

[44]  Pramod Kumar,et al.  Midodrine Improves the Tolerability of Diuretics in Patients with Acute-on-Chronic Liver Failure-A Pilot Study. , 2020, Journal of clinical and experimental hepatology.

[45]  M. Schwartz,et al.  PD‐1 inhibitor as bridge therapy to liver transplantation? , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[46]  D. Geller,et al.  The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 patients. , 2020, The oncologist.

[47]  J. Varghese,et al.  Role of therapeutic plasma exchange in acute liver failure due to yellow phosphorus poisoning , 2020, Indian Journal of Gastroenterology.

[48]  D. Valla,et al.  Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases , 2020, Hepatology.

[49]  Vinayak Nikam,et al.  The outcome of Living Donor Liver Transplant recipients with Recent Episodes of Spontaneous Bacterial Peritonitis. , 2020, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[50]  S. Taylor-Robinson,et al.  Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. , 2020, Journal of hepatology.

[51]  K. Reddy,et al.  In the era of direct-acting antivirals, liver transplant delisting due to clinical improvement for hepatitis C remains infrequent. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[52]  P. Angeli,et al.  Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome , 2020, Hepatology.

[53]  D. J. Kim,et al.  Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. , 2020, Journal of hepatology.

[54]  E. Tapper,et al.  Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis. , 2020, The American journal of gastroenterology.

[55]  R. Risco,et al.  A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation , 2020, JHEP reports : innovation in hepatology.

[56]  R. Moreau,et al.  Acute-on-Chronic Liver Failure. , 2020, The New England journal of medicine.

[57]  Samuel Hui,et al.  Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care , 2020, World journal of gastroenterology.

[58]  N. Chalasani,et al.  Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. , 2020, Journal of hepatology.

[59]  M. Rudler,et al.  Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. , 2020, Journal of hepatology.

[60]  Yuan Xu,et al.  Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation: A Meta‐Analysis , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[61]  Charles M. Miller,et al.  Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis. , 2020, Surgery.

[62]  R. Dhiman,et al.  Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. , 2020, The American journal of gastroenterology.

[63]  N. Heaton,et al.  Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[64]  O. Okoye,et al.  Tracheostomy Following Liver Transplantation. , 2020, Transplantation proceedings.

[65]  R. Sehgal,et al.  Comparative study of spironolactone and eplerenone in management of ascites in patients of cirrhosis of liver , 2020, European journal of gastroenterology & hepatology.

[66]  G. Lee,et al.  Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review , 2020, World journal of gastroenterology.

[67]  S. Sarin,et al.  Paracentesis‐Induced Circulatory Dysfunction With Modest‐Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute‐on‐Chronic Liver Failure , 2019, Hepatology.

[68]  William M. Lee,et al.  Acute liver failure , 2019, The Lancet.

[69]  M. Plauth,et al.  ESPEN guideline on clinical nutrition in liver disease. , 2019, Clinical nutrition.

[70]  H. Yamanaka-Okumura,et al.  Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning. , 2019, Clinical nutrition ESPEN.

[71]  M. Plauth,et al.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease. , 2019, Journal of hepatology.

[72]  R. Facchetti,et al.  Delisting HCV‐infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[73]  Amany A. Abdin,et al.  Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy , 2018, European journal of gastroenterology & hepatology.

[74]  M. Senzolo,et al.  Mortality in liver transplant recipients with portal vein thrombosis – an updated meta‐analysis , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[75]  P. Angeli,et al.  Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascites , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[76]  A. Sutton,et al.  Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis , 2018, Cochrane Database of Systematic Reviews.

[77]  Q. Xiong,et al.  Early predictors of acute hepatitis B progression to liver failure , 2018, PloS one.

[78]  J. Bajaj,et al.  Current Management of Hepatic Encephalopathy , 2018, The American Journal of Gastroenterology.

[79]  S. Gitto,et al.  Low molecular weight heparin does not increase bleeding and mortality post‐endoscopic variceal band ligation in cirrhotic patients , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[80]  E. Pose,et al.  Hepatorenal syndrome in the era of acute kidney injury , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[81]  Mayank Jain,et al.  SX-Ella Danis stent in massive upper gastrointestinal bleeding in cirrhosis – a case series , 2018, Clinical and experimental hepatology.

[82]  R. Bataller,et al.  Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. , 2018 .

[83]  S. Kim,et al.  Impact of Pretransplant Infections on Clinical Course in Liver Transplant Recipients. , 2018, Transplantation proceedings.

[84]  Avash Kalra,et al.  New paradigms for organ allocation and distribution in liver transplantation , 2018, Current opinion in gastroenterology.

[85]  R. Chung,et al.  Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[86]  Zhen Wang,et al.  Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis , 2018, Hepatology.

[87]  R. Jalan,et al.  Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. , 2017, Journal of hepatology.

[88]  V. Sundaram,et al.  The Braden Scale, A standard tool for assessing pressure ulcer risk, predicts early outcomes after liver transplantation , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[89]  S. Abd-Elsalam,et al.  Randomized controlled trial of scleroligation versus band ligation alone for eradication of gastroesophageal varices. , 2017, Gastrointestinal endoscopy.

[90]  G. Marchesini,et al.  Branched-chain amino acids for people with hepatic encephalopathy. , 2017, The Cochrane database of systematic reviews.

[91]  J. Raszeja-Wyszomirska,et al.  Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial. , 2017, Clinical nutrition.

[92]  M. Manns,et al.  EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. , 2017, Journal of hepatology.

[93]  A. Montano‐Loza,et al.  A multicenter study to define sarcopenia in patients with end‐stage liver disease , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[94]  N. Yellu,et al.  Population pharmacokinetic modeling of furosemide in patients with hypertension and fluid overload conditions , 2017, Pharmacological reports : PR.

[95]  William M. Lee,et al.  Budd‐chiari syndrome causing acute liver failure: A multicenter case series , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[96]  R. Moreau,et al.  Acute-on-chronic liver failure: an update , 2017, Gut.

[97]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[98]  L. Jeng,et al.  Management of renal dysfunction in patients with liver cirrhosis: role of pretransplantation hemodialysis and outcomes after liver transplantation. , 2016, Seminars in vascular surgery.

[99]  M. Rela,et al.  Liver transplantation in India , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[100]  William M. Lee,et al.  Acute liver injury and acute liver failure from mushroom poisoning in North America , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[101]  J. Bosch,et al.  Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial , 2016, Hepatology.

[102]  M. Trauner,et al.  The role of TIPS in the management of liver transplant candidates , 2016, United European gastroenterology journal.

[103]  G. Palù,et al.  The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial , 2016, Hepatology.

[104]  J. Lai.  Defining the threshold for too sick for transplant , 2016, Current opinion in organ transplantation.

[105]  J. Roberts,et al.  Intention to treat outcome of T1 hepatocellular carcinoma with the “wait and not ablate” approach until meeting T2 criteria for liver transplant listing , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[106]  R. Fimmers,et al.  The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis , 2016, Digestive Diseases and Sciences.

[107]  S. Caldwell,et al.  Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation , 2016, Digestive Diseases and Sciences.

[108]  C. Marroni.  Management of alcohol recurrence before and after liver transplantation. , 2015, Clinics and research in hepatology and gastroenterology.

[109]  Xinying Wang,et al.  Peri-operative immunonutrition in patients undergoing liver transplantation: a meta-analysis of randomized controlled trials. , 2015, Asia Pacific journal of clinical nutrition.

[110]  K. Reddy,et al.  High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of end‐stage liver disease , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[111]  M. Sawyer,et al.  Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis , 2015, Journal of cachexia, sarcopenia and muscle.

[112]  C. Jacquelinet,et al.  Patients with acute liver failure listed for superurgent liver transplantation in France: Reevaluation of the clichy‐villejuif criteria , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[113]  W. Bernal,et al.  Update on acute liver failure , 2015, Current opinion in critical care.

[114]  C. Strassburg,et al.  Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. , 2015, World journal of hepatology.

[115]  Shalimar,et al.  Management in acute liver failure. , 2015, Journal of clinical and experimental hepatology.

[116]  S. Uemoto,et al.  Perioperative nutritional therapy in liver transplantation , 2015, Surgery Today.

[117]  M. Álvarez-Mon,et al.  Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. , 2014, Journal of hepatology.

[118]  N. Heaton,et al.  Review article: liver transplantation for hepatocellular carcinoma – a critical appraisal of the current worldwide listing criteria , 2014, Alimentary pharmacology & therapeutics.

[119]  B. I. Kim,et al.  Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage , 2014, Hepatology.

[120]  G. D’Amico,et al.  Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients , 2014, Alimentary pharmacology & therapeutics.

[121]  A. Gasbarrini,et al.  Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up. , 2014, Transplantation reviews.

[122]  P. Angeli,et al.  Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real‐life cross‐sectional study , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[123]  R. Porte,et al.  Routine coagulation assays underestimate levels of antithrombin‐dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis , 2013, British journal of haematology.

[124]  D. Samuel,et al.  Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure , 2013, Annals of Internal Medicine.

[125]  P. Mannucci,et al.  Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. , 2013, Journal of hepatology.

[126]  M. Kumar,et al.  Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute‐on‐chronic liver failure , 2013, Journal of gastroenterology and hepatology.

[127]  M. Mcphail,et al.  Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. , 2013, Journal of hepatology.

[128]  R. Butterworth,et al.  The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus , 2013, Hepatology.

[129]  M. Peters,et al.  Diagnosis and Management of Delayed Hemoperitoneum Following Therapeutic Paracentesis , 2013, Proceedings.

[130]  M. Poca,et al.  Transfusion strategies for acute upper gastrointestinal bleeding. , 2013, The New England journal of medicine.

[131]  D. Valla,et al.  Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. , 2012, Gastroenterology.

[132]  S. Yagi,et al.  Pre- and perioperative factors affecting infection after living donor liver transplantation. , 2012, Nutrition.

[133]  A. Davenport,et al.  Evaluation of coagulation abnormalities in acute liver failure. , 2012, Journal of hepatology.

[134]  William M. Lee,et al.  Pathogenesis of liver injury in acute liver failure. , 2012, Gastroenterology.

[135]  J. García‐Pagán,et al.  Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[136]  D. Valla,et al.  Portal vein thrombosis, cirrhosis, and liver transplantation. , 2012, Journal of hepatology.

[137]  M. Pavesi,et al.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study , 2012, Hepatology.

[138]  M. Rela,et al.  Perioperative bacterial infections in deceased donor and living donor liver transplant recipients. , 2012, Journal of clinical and experimental hepatology.

[139]  S. Khanal,et al.  Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure , 2012, Gut.

[140]  M. Englesbe,et al.  Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[141]  Linda L. Liu,et al.  Critical care of the end‐stage liver disease patient awaiting liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[142]  G. Auzinger,et al.  Outcomes of Severe Pregnancy‐Related Liver Disease: Refining the Role of Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[143]  A. Burroughs,et al.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.

[144]  F. Nevens,et al.  Early use of TIPS in patients with cirrhosis and variceal bleeding. , 2010, The New England journal of medicine.

[145]  William M. Lee,et al.  Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. , 2009, Gastroenterology.

[146]  F. Larsen,et al.  Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. , 2007, Journal of Hepatology.

[147]  A. Sanyal,et al.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. , 2007, The American journal of gastroenterology.

[148]  D. Samuel,et al.  Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[149]  K. Mimidis,et al.  Eplerenone relieves spironolactone-induced painful gynaecomastia in patients with decompensated hepatitis B-related cirrhosis , 2007, Scandinavian journal of gastroenterology.

[150]  P. D. de Groot,et al.  Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity , 2006, Hepatology.

[151]  M. Davies,et al.  Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results. , 2006, Journal of vascular and interventional radiology : JVIR.

[152]  D. Samuel,et al.  Herpes simplex virus‐associated acute liver failure: A difficult diagnosis with a poor prognosis , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[153]  C. Brensinger,et al.  Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[154]  M. Mauro,et al.  Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. , 2005, Journal of vascular and interventional radiology : JVIR.

[155]  P. Hayes,et al.  Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. , 2004, Gastroenterology.

[156]  R. Moreau,et al.  Clinical characteristics and outcome of patients with cirrhosis and refractory ascites , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[157]  R. Moreau,et al.  The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club , 2003, Hepatology.

[158]  T. Fukuda,et al.  Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. , 2001, Journal of vascular and interventional radiology : JVIR.

[159]  A. Gatta,et al.  The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis , 2000, Hepatology.

[160]  S. Olliff,et al.  Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. , 2000, Transplantation.

[161]  M. Manns,et al.  Hypermetabolism in clinically stable patients with liver cirrhosis. , 1999, The American journal of clinical nutrition.

[162]  T. Poynard,et al.  Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis , 1998, Digestion.

[163]  R. Hughes,et al.  Effect of ELAD Liver Support on Plasma HGF and TGF–β1 in Acute Liver Failure , 1996, The International journal of artificial organs.

[164]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[165]  J. Llach,et al.  Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration , 1992, Hepatology.

[166]  R Williams,et al.  Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.

[167]  U. Kabadi.  The association of hepatic glycogen depletion with hyperammonemia in cirrhosis , 1987, Hepatology.

[168]  R. Dhiman,et al.  Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. , 2019, Journal of clinical and experimental hepatology.

[169]  G. Auzinger,et al.  High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. , 2016, Journal of hepatology.

[170]  M. Morgan,et al.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. , 2016, The Cochrane database of systematic reviews.

[171]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[172]  J. Wendon,et al.  Acute liver failure. , 2013, The New England journal of medicine.

[173]  Patrick M M Bossuyt,et al.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. , 2012, The Lancet. Oncology.

[174]  M. Álvares-da-Silva,et al.  Prevalence of diabetes mellitus and impaired glucose tolerance in patients with decompensated cirrhosis being evaluated for liver transplantation: the utility of oral glucose tolerance test. , 2010, Arquivos de gastroenterologia.

[175]  N. Mattek,et al.  Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. , 2007, Gastrointestinal endoscopy.

[176]  Roger Williams,et al.  Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. , 1986, Journal of hepatology.